FDA Clinical Trials FDA Regulations Regulatory Agencies Mifepristone EU Regulations NHS Alzheimer's Disease FDA Approval Generic Drugs NHS Policies Esketamine FDA Drug Approval Xolair Cardiovascular Health Regulations Guidelines TGA NHS Treatments Regulatory Authorities Infant Medicine Insurance Coverage Biotechnology Regulatory Affairs Therapeutic Goods Administration Mounjaro Vorasidenib MHRA EU Commission European Medicines Agency Radioligand Therapy GLP-1 Drugs Antibiotics Sanofi Imdelltra Regulatory Processes Blood Disorder Treatment China Non-Hormonal Treatments FDA Processes Weight Management Bristol Myers Squibb Antipsychotic Medications Public Health Eli Lilly Nasal Spray
The agency said it needs additional evidence of effectiveness before assessing the drug for hypertension tied to hypercortisolism.
